Astrana Health (ASTH) Competitors $33.76 -0.29 (-0.85%) Closing price 04:00 PM EasternExtended Trading$33.78 +0.02 (+0.07%) As of 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ASTH vs. QXO, ETSY, GLOB, WSC, LYFT, AMTM, MARA, RELY, TNET, and STNEShould you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include QXO (QXO), Etsy (ETSY), Globant (GLOB), WillScot Mobile Mini (WSC), Lyft (LYFT), Amentum (AMTM), MARA (MARA), Remitly Global (RELY), TriNet Group (TNET), and StoneCo (STNE). These companies are all part of the "business services" industry. Astrana Health vs. QXO Etsy Globant WillScot Mobile Mini Lyft Amentum MARA Remitly Global TriNet Group StoneCo QXO (NASDAQ:QXO) and Astrana Health (NASDAQ:ASTH) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, community ranking, media sentiment, valuation, profitability and analyst recommendations. Which has more risk and volatility, QXO or ASTH? QXO has a beta of 2.16, meaning that its stock price is 116% more volatile than the S&P 500. Comparatively, Astrana Health has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Which has preferable valuation & earnings, QXO or ASTH? Astrana Health has higher revenue and earnings than QXO. QXO is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQXO$56.87M104.35-$1.07M-$9.78-1.48Astrana Health$2.03B0.83$60.72M$0.8937.93 Is QXO or ASTH more profitable? QXO has a net margin of 30.08% compared to Astrana Health's net margin of 3.63%. Astrana Health's return on equity of 9.37% beat QXO's return on equity.Company Net Margins Return on Equity Return on Assets QXO30.08% 1.58% 1.30% Astrana Health 3.63%9.37%5.32% Do analysts rate QXO or ASTH? Astrana Health has a consensus target price of $53.29, suggesting a potential upside of 57.84%. Given Astrana Health's stronger consensus rating and higher possible upside, analysts clearly believe Astrana Health is more favorable than QXO.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QXO 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Astrana Health 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.80 Does the MarketBeat Community prefer QXO or ASTH? Astrana Health received 16 more outperform votes than QXO when rated by MarketBeat users. CompanyUnderperformOutperformQXON/AN/AAstrana HealthOutperform Votes1680.00% Underperform Votes420.00% Does the media prefer QXO or ASTH? In the previous week, Astrana Health had 1 more articles in the media than QXO. MarketBeat recorded 6 mentions for Astrana Health and 5 mentions for QXO. Astrana Health's average media sentiment score of 1.63 beat QXO's score of 1.26 indicating that Astrana Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QXO 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Astrana Health 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders and institutionals hold more shares of QXO or ASTH? 58.7% of QXO shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 51.3% of QXO shares are held by insiders. Comparatively, 8.5% of Astrana Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryAstrana Health beats QXO on 13 of the 18 factors compared between the two stocks. Remove Ads Get Astrana Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASTH vs. The Competition Export to ExcelMetricAstrana HealthManagement consulting services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.69B$2.06B$5.33B$7.57BDividend YieldN/A2.97%5.11%4.32%P/E Ratio25.9710.0121.7317.81Price / Sales0.8317.65379.1994.60Price / Cash26.1562.1338.1534.64Price / Book3.196.106.464.00Net Income$60.72M$106.41M$3.20B$247.23M7 Day Performance8.59%8.27%6.54%7.26%1 Month Performance15.06%-4.30%-8.55%-6.26%1 Year Performance-13.77%33.76%10.33%-0.18% Astrana Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASTHAstrana Health3.7974 of 5 stars$33.76-0.9%$53.29+57.8%-16.4%$1.69B$2.03B25.971,900Positive NewsQXOQXO1.0611 of 5 stars$13.52-3.5%N/AN/A$5.53B$56.87M-1.48195Short Interest ↑Gap DownETSYEtsy4.6413 of 5 stars$43.64-1.8%$58.38+33.8%-34.9%$4.76B$2.81B18.412,790Analyst ForecastGLOBGlobant4.6124 of 5 stars$102.39+1.8%$216.56+111.5%-43.8%$4.51B$2.42B27.5227,100Analyst DowngradeNews CoveragePositive NewsGap DownHigh Trading VolumeWSCWillScot Mobile Mini4.0968 of 5 stars$23.99+1.5%$42.00+75.1%-40.4%$4.40B$2.40B159.944,500Short Interest ↑Positive NewsLYFTLyft4.463 of 5 stars$10.47-3.4%$16.66+59.1%-42.0%$4.38B$5.79B174.504,420AMTMAmentum3.2679 of 5 stars$16.92-3.2%$26.20+54.9%N/A$4.12B$9.82B0.0053,000Analyst ForecastNews CoveragePositive NewsMARAMARA3.3809 of 5 stars$11.26-0.4%$22.80+102.5%-19.6%$3.89B$656.38M14.259RELYRemitly Global3.9117 of 5 stars$18.81+0.8%$27.25+44.9%+6.8%$3.77B$1.26B-99.002,700Positive NewsTNETTriNet Group4.0255 of 5 stars$73.66-0.1%$105.67+43.5%-37.7%$3.65B$5.05B21.543,600Positive NewsSTNEStoneCo4.3264 of 5 stars$10.62+0.4%$14.50+36.5%-27.0%$3.28B$12.74B8.3017,091 Remove Ads Related Companies and Tools Related Companies QXO Competitors Etsy Competitors Globant Competitors WillScot Mobile Mini Competitors Lyft Competitors Amentum Competitors MARA Competitors Remitly Global Competitors TriNet Group Competitors StoneCo Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASTH) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ASTH Stock Free ASTH Stock Alerts